Deutsche Bank says it’s now overweight Europe stocks vs. the U.S. Valuation is just one reason.

• 

  Arsenal season may just be cursed as loss to Newcastle shows, but there's reason for hope amid the misfortune

  The Gunners have not had luck on their side, but manager Mikel Arteta says they are in better position than last season
  
  CBS Sports - 2h

• 3 reasons Trump keeps floating U.S. control of Greenland — including one tied to tax cuts

  Here’s why President-elect Donald Trump keeps talking about one idea from his first term in office — getting control of Greenland, the giant territory controlled by Denmark.
  
  MarketWatch - 4h

• Bank of America’s stock could go up 20% in 2025, says this analyst

  UBS’s Erika Najarian upgrades Bank of America to buy from neutral
  
  MarketWatch - 22h

• Indian officials confirm first cases of HMPV, say "no reason to worry"

  Officials in India have confirmed the country's first 7 cases of human metapneumovirus, which is reportedly surging in neighboring China.
  
  CBS News - 23h

• Why bank stocks care that Michael Barr is stepping down as top Fed banking cop

  As vice chair of supervision, Barr was leading the effort to raise capital requirements for banks.
  
  MarketWatch - 1d

• Citigroup’s stock is a banking-sector bargain as ‘inflection point’ looms, analyst suggests

  Barclays analyst Jason Goldberg upgrades Citigroup to overweight from equal weight on bullish 2025 prospects.
  
  MarketWatch - 2d
• 

  It is misleading to tar all Europe’s ‘new right’ parties with one brush

  Some movements are correctly labelled extremist but others have a better claim to democratic credentials
  
  Financial Times - 3d
• 

  USB-C Is Now the Law of the Land in Europe

  Apple has already pulled devices to comply with the European Commission’s new Common Charger Directive.
  
  Wired - 4d
• 

  Here’s the Reason U.S. Auto Sales Could Accelerate in 2025

  Reduced inventories of cars amid enduring supply chain limitations are finally expanding again, lowering prices for buyers, and fueling sales growth for dealers.
  
  Inc. - 5d

More from MarketWatch

• AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

  Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
  
  MarketWatch - 26m

• Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

  Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
  
  MarketWatch - 27m

• Jobless claims fall to a nearly one-year low as Trump set to take office

  The number of people who applied for unemployment benefits in the first week of the new year fell to an 11-month low, the latest sign layoffs remain extremely low even as businesses cut back on ...
  
  MarketWatch - 33m

• Trump’s push for SALT tax reform threatened by hardline GOP budget hawks

  The path of least resistance could be $5 trillion in new government debt.
  
  MarketWatch - 34m

• The market’s wobbling. Here are BlackRock’s shields for the biggest risks.

  Here are the hedges the $11 trillion asset manager recommends for the concerns weighing on investor minds.
  
  MarketWatch - 42m

More in Business

• 

  EU will defend borders, says French minister in response to Trump’s Greenland threats

  European leaders also criticise Trump ally Elon Musk over support for far-right movements
  
  Financial Times - 6m

• We're locking in roughly 100% gains on a stock that has fallen out of favor

  The stock has been downgraded by three analysts this week.
  
  CNBC - 15m

• Quantum stocks like Rigetti plunge after Nvidia's Huang says the computers are 15 to 30 years away

  Quantum computing stocks dropped Wednesday after Nvidia CEO Jensen Huang declared that useful quantum computers are likely decades in the future.
  
  CNBC - 24m

• AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

  Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
  
  MarketWatch - 26m

• Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

  Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
  
  MarketWatch - 27m